See more : SportsHero Limited (NIROF) Income Statement Analysis – Financial Results
Complete financial analysis of Hologic, Inc. (HOLX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Hologic, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Scheid Vineyards Inc. (SVIN) Income Statement Analysis – Financial Results
- Anrakutei Co., Ltd. (7562.T) Income Statement Analysis – Financial Results
- Oceanic Beverages Co., Inc. (1213.TW) Income Statement Analysis – Financial Results
- Aquarius Engines (A.M) Ltd. (AQUA.TA) Income Statement Analysis – Financial Results
- Yasho Industries Limited (YASHO.BO) Income Statement Analysis – Financial Results
Hologic, Inc. (HOLX)
About Hologic, Inc.
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.03B | 4.03B | 4.86B | 5.63B | 3.78B | 3.37B | 3.22B | 3.06B | 2.83B | 2.71B | 2.53B | 2.49B | 2.00B | 1.79B | 1.68B | 1.64B | 1.67B | 738.37M | 462.68M | 287.68M | 228.71M | 204.04M | 190.19M | 178.49M | 93.75M | 84.10M | 115.60M | 106.70M | 88.20M | 43.40M | 38.50M | 24.80M | 26.20M | 17.10M | 19.80M | 11.40M |
| Cost of Revenue | 1.80B | 1.96B | 1.87B | 1.84B | 1.55B | 2.06B | 1.52B | 1.44B | 1.27B | 1.27B | 1.29B | 1.33B | 1.01B | 866.17M | 942.91M | 779.65M | 781.98M | 392.80M | 269.15M | 174.66M | 143.34M | 130.46M | 118.38M | 116.18M | 59.18M | 46.80M | 54.00M | 46.20M | 40.40M | 21.50M | 20.30M | 13.30M | 13.20M | 8.20M | 9.20M | 4.10M |
| Gross Profit | 2.23B | 2.07B | 3.00B | 3.80B | 2.23B | 1.31B | 1.70B | 1.62B | 1.56B | 1.43B | 1.25B | 1.16B | 994.44M | 923.18M | 736.64M | 857.49M | 892.52M | 345.57M | 193.53M | 113.03M | 85.37M | 73.58M | 71.82M | 62.31M | 34.56M | 37.30M | 61.60M | 60.50M | 47.80M | 21.90M | 18.20M | 11.50M | 13.00M | 8.90M | 10.60M | 7.30M |
| Gross Profit Ratio | 55.28% | 51.40% | 61.64% | 67.39% | 58.98% | 38.85% | 52.73% | 52.99% | 55.19% | 52.96% | 49.22% | 46.60% | 49.66% | 51.59% | 43.86% | 52.38% | 53.30% | 46.80% | 41.83% | 39.29% | 37.33% | 36.06% | 37.76% | 34.91% | 36.87% | 44.35% | 53.29% | 56.70% | 54.20% | 50.46% | 47.27% | 46.37% | 49.62% | 52.05% | 53.54% | 64.04% |
| Research & Development | 272.80M | 294.30M | 283.40M | 276.30M | 222.50M | 232.20M | 218.70M | 232.80M | 232.10M | 214.90M | 203.20M | 197.65M | 130.96M | 116.70M | 104.31M | 94.33M | 81.42M | 44.48M | 28.29M | 18.62M | 16.66M | 18.38M | 20.36M | 23.33M | 17.18M | 12.70M | 9.80M | 8.50M | 7.30M | 4.30M | 3.40M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 409.40M | 392.40M | 407.70M | 433.20M | 356.00M | 332.30M | 366.10M | 343.30M | 267.30M | 261.00M | 259.80M | 227.68M | 220.04M | 158.79M | 159.74M | 148.83M | 147.41M | 0.00 | 42.55M | 27.58M | 24.36M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 585.40M | 595.20M | 630.30M | 561.20M | 484.60M | 564.90M | 544.60M | 498.60M | 415.10M | 363.00M | 331.70M | 342.14M | 322.31M | 286.73M | 247.37M | 238.98M | 261.52M | 0.00 | 55.91M | 34.20M | 31.76M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 994.80M | 987.60M | 1.04B | 994.40M | 840.60M | 897.20M | 910.70M | 841.90M | 682.40M | 624.00M | 591.50M | 569.82M | 542.36M | 445.52M | 407.12M | 387.80M | 408.93M | 147.75M | 98.46M | 61.78M | 56.12M | 52.17M | 47.23M | 56.27M | 40.32M | 30.70M | 39.10M | 28.30M | 34.80M | 12.30M | 10.10M | 13.10M | 11.40M | 8.40M | 7.20M | 5.50M |
| Other Expenses | 77.60M | -1.70M | 45.20M | 42.20M | 39.70M | 52.00M | 7.60M | 12.90M | 26.60M | -11.00M | -3.60M | 3.61M | 7.26M | -4.18M | 901.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.35B | 1.31B | 1.37B | 1.31B | 1.10B | 1.18B | 1.19B | 1.14B | 1.00B | 949.10M | 908.50M | 880.06M | 745.81M | 536.05M | 566.28M | 533.34M | 518.48M | 197.82M | 123.29M | 80.39M | 72.78M | 70.56M | 67.59M | 79.60M | 61.92M | 46.90M | 50.80M | 38.10M | 35.70M | 17.20M | 14.10M | 13.50M | 11.70M | 8.70M | 7.40M | 5.60M |
| Cost & Expenses | 3.15B | 3.27B | 3.23B | 3.15B | 2.65B | 3.24B | 2.71B | 2.58B | 2.27B | 2.22B | 2.19B | 2.21B | 1.75B | 1.40B | 1.51B | 1.31B | 1.30B | 590.62M | 392.44M | 255.05M | 216.12M | 201.01M | 185.97M | 195.78M | 121.11M | 93.70M | 104.80M | 84.30M | 76.10M | 38.70M | 34.40M | 26.80M | 24.90M | 16.90M | 16.60M | 9.70M |
| Interest Income | 108.70M | 120.50M | 12.90M | 1.40M | 4.30M | 4.60M | 6.30M | 3.80M | 700.00K | 1.30M | 1.30M | 1.30M | 2.34M | 1.86M | 1.28M | 1.16M | 4.53M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 122.10M | 111.10M | 95.10M | 93.60M | 116.50M | 140.80M | 148.70M | 153.20M | 155.30M | 205.50M | 220.60M | 281.08M | 140.29M | 114.85M | 126.21M | 73.16M | 84.91M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 309.00M | 323.40M | 430.10M | 406.90M | 376.00M | 463.00M | 480.30M | 449.20M | 465.40M | 491.40M | 113.80M | 112.60M | 72.04M | 58.33M | 54.86M | 51.21M | 172.95M | 31.16M | 16.13M | 7.57M | 7.59M | 7.41M | 7.48M | 8.74M | 4.42M | 3.50M | 1.90M | 1.30M | 900.00K | 600.00K | 600.00K | 400.00K | 300.00K | 300.00K | 200.00K | 100.00K |
| EBITDA | 1.30B | 1.11B | 2.11B | 2.86B | 1.50B | 346.10M | 210.40M | 1.83B | 1.04B | 874.10M | 791.90M | -395.88M | 424.40M | 646.97M | 366.88M | -1.75B | -21.28M | 178.91M | 70.55M | 40.21M | 20.18M | 3.03M | 11.70M | -8.55M | -22.94M | -6.10M | 12.70M | 23.70M | 18.30M | 5.30M | 4.70M | -1.60M | 1.60M | 500.00K | 3.40M | 1.80M |
| EBITDA Ratio | 32.16% | 29.87% | 43.28% | 51.24% | 40.09% | 17.74% | 31.14% | 31.05% | 37.13% | 35.69% | 17.67% | 15.95% | 16.37% | 27.40% | 13.49% | 23.00% | 67.05% | 24.23% | 21.87% | 13.98% | 8.82% | 5.11% | 7.24% | -3.94% | -18.89% | -6.66% | 6.40% | 17.34% | 9.18% | 17.28% | 11.69% | -7.66% | 3.05% | -1.75% | 14.14% | 14.91% |
| Operating Income | 882.60M | 668.40M | 1.64B | 2.48B | 1.11B | 134.40M | -237.90M | 1.37B | 548.60M | 455.10M | 279.70M | -906.28M | 113.72M | 374.45M | 69.94M | -2.02B | -197.54M | 147.75M | 50.34M | 32.63M | 12.59M | 3.03M | 2.16M | -18.81M | -27.36M | -9.60M | 10.80M | 22.40M | 12.10M | 4.70M | 4.10M | -2.00M | 1.30M | 200.00K | 3.20M | 1.70M |
| Operating Income Ratio | 21.90% | 16.58% | 33.73% | 44.04% | 29.26% | 3.99% | -7.39% | 44.80% | 19.37% | 16.82% | 11.05% | -36.36% | 5.68% | 20.93% | 4.16% | -123.18% | -11.80% | 20.01% | 10.88% | 11.34% | 5.50% | 1.48% | 1.13% | -10.54% | -29.18% | -11.41% | 9.34% | 20.99% | 13.72% | 10.83% | 10.65% | -8.06% | 4.96% | 1.17% | 16.16% | 14.91% |
| Total Other Income/Expenses | -17.50M | 7.70M | -52.00M | -119.20M | -103.10M | -296.30M | -180.70M | -139.70M | -133.30M | -277.90M | -231.60M | -286.68M | -175.36M | -147.06M | -124.93M | -72.00M | -81.60M | 737.00K | -11.92M | 2.06M | 341.00K | 240.00K | -2.41M | -1.88M | -1.66M | 3.80M | 5.40M | 5.10M | -300.00K | -2.10M | 200.00K | -100.00K | 800.00K | 800.00K | 500.00K | 0.00 |
| Income Before Tax | 865.10M | 676.10M | 1.59B | 2.36B | 1.00B | -95.30M | -418.60M | 1.23B | 415.30M | 177.20M | 48.10M | -1.19B | -61.66M | 227.39M | -54.99M | -2.09B | -279.14M | 148.49M | 53.22M | 34.70M | 12.93M | 3.27M | -250.00K | -20.68M | -29.02M | -5.80M | 16.20M | 27.50M | 17.10M | 2.60M | 4.30M | -2.10M | 2.10M | 1.00M | 3.70M | 1.70M |
| Income Before Tax Ratio | 21.46% | 16.78% | 32.66% | 41.92% | 26.53% | -2.83% | -13.01% | 40.23% | 14.66% | 6.55% | 1.90% | -47.87% | -3.08% | 12.71% | -3.27% | -127.58% | -16.67% | 20.11% | 11.50% | 12.06% | 5.65% | 1.60% | -0.13% | -11.59% | -30.95% | -6.90% | 14.01% | 25.77% | 19.39% | 5.99% | 11.17% | -8.47% | 8.02% | 5.85% | 18.69% | 14.91% |
| Income Tax Expense | 75.60M | 220.10M | 286.20M | 491.40M | -108.60M | -55.10M | -307.30M | 475.00M | 84.50M | 45.60M | 30.80M | -20.12M | 11.97M | 70.24M | 7.82M | 87.56M | 106.48M | 53.91M | 25.80M | 6.44M | 763.00K | 176.00K | -429.00K | 169.00K | -10.40M | -2.10M | 5.80M | 9.80M | 5.70M | 700.00K | 1.30M | -300.00K | 600.00K | 300.00K | 1.10M | 300.00K |
| Net Income | 789.50M | 456.00M | 1.30B | 1.87B | 1.12B | -40.20M | -111.30M | 755.50M | 330.80M | 131.60M | 17.30M | -1.17B | -73.63M | 157.15M | -62.81M | -2.18B | -385.62M | 94.58M | 27.42M | 28.26M | 12.16M | 2.88M | 179.00K | -20.85M | -18.62M | -3.70M | 10.40M | 17.70M | 11.40M | 1.90M | 3.00M | -1.80M | 1.50M | 700.00K | 2.60M | 1.40M |
| Net Income Ratio | 19.59% | 11.31% | 26.77% | 33.23% | 29.53% | -1.19% | -3.46% | 24.70% | 11.68% | 4.87% | 0.68% | -47.06% | -3.68% | 8.78% | -3.74% | -132.93% | -23.03% | 12.81% | 5.93% | 9.82% | 5.32% | 1.41% | 0.09% | -11.68% | -19.86% | -4.40% | 9.00% | 16.59% | 12.93% | 4.38% | 7.79% | -7.26% | 5.73% | 4.09% | 13.13% | 12.28% |
| EPS | 3.35 | 1.85 | 5.18 | 7.28 | 4.24 | -0.15 | -0.40 | 2.70 | 1.18 | 0.47 | 0.06 | -4.36 | -0.28 | 0.60 | -0.24 | -8.48 | -1.57 | 0.88 | 0.30 | 0.33 | 0.15 | 0.04 | 0.00 | -0.34 | -0.30 | -0.07 | 0.20 | 0.34 | 0.24 | 0.05 | 0.12 | -0.06 | 0.05 | 0.02 | 0.09 | 0.07 |
| EPS Diluted | 3.32 | 1.83 | 5.13 | 7.21 | 4.21 | -0.15 | -0.40 | 2.64 | 1.16 | 0.45 | 0.06 | -4.36 | -0.28 | 0.59 | -0.24 | -8.48 | -1.57 | 0.86 | 0.28 | 0.32 | 0.14 | 0.04 | 0.00 | -0.34 | -0.30 | -0.07 | 0.19 | 0.33 | 0.23 | 0.05 | 0.12 | -0.06 | 0.05 | 0.02 | 0.09 | 0.06 |
| Weighted Avg Shares Out | 235.72M | 246.77M | 251.53M | 257.05M | 262.73M | 269.41M | 275.11M | 279.81M | 280.21M | 280.57M | 275.50M | 268.70M | 262.86M | 261.10M | 258.74M | 256.55M | 245.97M | 106.87M | 93.02M | 85.65M | 81.03M | 78.52M | 73.68M | 61.90M | 61.28M | 56.92M | 53.33M | 51.68M | 47.01M | 35.01M | 24.49M | 31.30M | 31.58M | 31.11M | 28.11M | 8.71M |
| Weighted Avg Shares Out (Dil) | 237.55M | 248.83M | 253.85M | 259.71M | 264.61M | 269.41M | 275.11M | 285.65M | 286.16M | 289.54M | 278.36M | 268.70M | 264.04M | 264.31M | 258.74M | 256.55M | 245.97M | 109.67M | 97.24M | 90.25M | 85.19M | 80.52M | 76.77M | 61.90M | 61.28M | 56.92M | 55.47M | 54.46M | 50.11M | 36.60M | 24.49M | 31.30M | 31.58M | 31.11M | 28.11M | 8.71M |
Hologic (HOLX) Rises Yet Lags Behind Market: Some Facts Worth Knowing
Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2024 on Monday, November 4, 2024
Hologic (HOLX) Stock Sinks As Market Gains: Here's Why
Hologic CEO Steve MacMillan on breast cancer detection, future of AI-powered diagnostics
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know
Hologic Unveils #BustTheMyth Campaign to Debunk Breast Cancer Myths and Empower Women This Breast Cancer Awareness Month
HOLX Stock Gains From New Offerings Despite Macro Issues
Is HOLX Stock a Smart Hold for Your Portfolio Right Now?
Here's Why Hologic (HOLX) is a Strong Value Stock
Hologic (HOLX) Falls More Steeply Than Broader Market: What Investors Need to Know
Source: https://incomestatements.info
Category: Stock Reports